欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子化合物 > 小分子抑制剂 > Garenoxacin

商品分类

浏览历史

S84509

Garenoxacin

源叶(MedMol) 98%
  • 英文名:
  • Garenoxacin
  • 别名:
  • 1-环丙基-8-(二氟甲氧基)-7-[(1R)-2,3-二氢-1-甲基-1H-异吲哚-5-基]-1,4-二氢-4-氧代-3-喹啉甲酸甲磺酸盐一水合物;甲磺酸加雷沙星一水合物;甲磺酸加雷沙星;1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quin
  • CAS号:
  • 223652-90-2
  • 分子式:
  • C23H20F2N2O4.CH4O3S.H2O
  • 分子量:
  • 540.53
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S84509-5mg 98% ¥500.00元 预计交期:2-3天 0 0 0 EA 加入购物车
源叶(MedMol) S84509-10mg 98% ¥700.00元 预计交期:2-3天 0 0 0 EA 加入购物车
源叶(MedMol) S84509-50mg 98% ¥2400.00元 预计交期:2-3天 0 0 0 EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: Garenoxacin (BMS284756) Mesylate hydrate is an orally active quinolone antibiotic and has a broad spectrum of activity against a wide array of gram-positive and gram-negative bacteria, anaerobes, and fastidious organisms
  • 靶点: Quinolone;Gyrase:1.25 μg/mL (IC50);TOPO IV:1.5-2.5 μg/mL (IC50)
  • 体内研究: Garenoxacin (12.5-50 mg/kg; s.c.; once) is highly effective against the wild-type strain and mutants harboring a single mutation in a mouse pneumonia model with S. pneumonia infection. Garenoxacin (10 and 30 mg/kg; p.o.; once) reduces the viable cell counts in the lungs and significantly prolongs survival on experimental secondary pneumococcal pneumonia caused by S. pneumoniae D-979 in BALB/c female mice Animal Model: Swiss mice with S. pneumonia infection. Dosage: 12.5, 25 and 50 mg/kg Administration: Subcutaneous injection, once Result: Significantly improved the survival rate.
  • 参考文献:
    1. Waites KB, et al. In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother. 2003 Jan;47(1):161-5. 2. Ince D, et al. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone. Antimicrob Agents Chemother. 2002 Nov;46(11):3370-80. 3. Zhao X, et al. Mutant prevention concentration of garenoxacin (BMS-284756) for ciprofloxacin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2003 Mar;47(3):1023-7. [Content Brief] 4. Azoulay-Dupuis E, et al. Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model. Antimicrob Agents Chemother. 2004 Mar;48(3):765-73. 5. Fukuda Y, et al. Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infection. Diagn Microbiol Infect Dis. 2014 Feb;78(2):168-71.
  • 溶解性: Soluble  in  DMSO、H2O
  • 保存条件: 2-8℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 1.85 ml 9.25 ml 18.5 ml
    5 mM 0.37 ml 1.85 ml 3.7 ml
    10 mM 0.185 ml 0.925 ml 1.85 ml
    50 mM 0.037 ml 0.185 ml 0.37 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。